UNS 0.00% 0.5¢ unilife corporation

Strategic direction

  1. 1,266 Posts.
    PFS programs, Sanofi, 150m to maintain exclusivity, Hikma 175m after Rapid ramp up(?).
    Biodel

    ended. Depot ject unknown pharma unknown revenue unknown volumes.

    AbbVie with Finesse and Lisa status unknown.

    Value proposition for sale,license outsource obligations unknown.

    Currently known three wearable programs Sanofi, Mefimmune, Amgem.

    We await the new roadmap. RRM
 
watchlist Created with Sketch. Add UNS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.